Segall Bryant & Hamill’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,000
| Closed | -$239K | – | 506 |
|
|
2023
Q2 | $239K | Hold |
3,000
| – | – | ﹤0.01% | 662 |
|
|
2023
Q1 | $216K | Hold |
3,000
| – | – | ﹤0.01% | 688 |
|
|
2022
Q4 | $246K | Hold |
3,000
| – | – | ﹤0.01% | 674 |
|
|
2022
Q3 | $234K | Sell |
3,000
-1,500
| -33% | -$120K | ﹤0.01% | 683 |
|
|
2022
Q2 | $303K | Buy |
+4,500
| New | +$314K | ﹤0.01% | 662 |
|
|
2020
Q2 | – | Sell |
-10,289
| Closed | -$189K | – | 774 |
|
|
2020
Q1 | $189K | Sell |
10,289
-1,500
| -13% | -$42.9K | ﹤0.01% | 745 |
|
|
2019
Q4 | $392K | Hold |
11,789
| – | – | 0.01% | 692 |
|
|
2019
Q3 | $367K | Sell |
11,789
-983
| -8% | -$29.9K | 0.01% | 702 |
|
|
2019
Q2 | $445K | Sell |
12,772
-2,166
| -14% | -$70K | 0.01% | 680 |
|
|
2019
Q1 | $439K | Sell |
14,938
-3,734
| -20% | -$106K | 0.01% | 680 |
|
|
2018
Q4 | $480K | Sell |
18,672
-25,896
| -58% | -$896K | 0.01% | 653 |
|
|
2018
Q3 | $1.57M | Sell |
44,568
-211
| -0.5% | -$8.41K | 0.02% | 478 |
|
|
2018
Q2 | $1.83M | Buy |
44,779
+23,427
| +110% | +$945K | 0.03% | 443 |
|
|
2018
Q1 | $837K | Hold |
21,352
| – | – | 0.02% | 370 |
|
|
2017
Q4 | $697K | Hold |
21,352
| – | – | 0.02% | 376 |
|
|
2017
Q3 | $1.02M | Buy |
21,352
+65
| +0.3% | +$3.17K | 0.02% | 355 |
|
|
2017
Q2 | $1.05M | Hold |
21,287
| – | – | 0.02% | 358 |
|
|
2017
Q1 | $928K | Sell |
21,287
-500
| -2% | -$20.3K | 0.02% | 353 |
|
|
2016
Q4 | $721K | Sell |
21,787
-1,889
| -8% | -$73.3K | 0.02% | 381 |
|
|
2016
Q3 | $1.17M | Buy |
23,676
+10,026
| +73% | +$522K | 0.03% | 337 |
|
|
2016
Q2 | $756K | Hold |
13,650
| – | – | 0.02% | 378 |
|
|
2016
Q1 | $752K | Buy |
13,650
+150
| +1% | +$8.56K | 0.02% | 377 |
|
|
2015
Q4 | $843K | Hold |
13,500
| – | – | 0.02% | 353 |
|
|
2015
Q3 | $895K | Hold |
13,500
| – | – | 0.02% | 356 |
|
|
2015
Q2 | $1.06M | Hold |
13,500
| – | – | 0.02% | 345 |
|
|
2015
Q1 | $967K | Hold |
13,500
| – | – | 0.02% | 346 |
|
|
2014
Q4 | $826K | Hold |
13,500
| – | – | 0.02% | 370 |
|
|
2014
Q3 | $655K | Hold |
13,500
| – | – | 0.02% | 396 |
|
|
2014
Q2 | $614K | Sell |
13,500
-14,000
| -51% | -$615K | 0.01% | 404 |
|
|
2014
Q1 | $1.24M | Hold |
27,500
| – | – | 0.03% | 311 |
|
|
2013
Q4 | $1.3M | Hold |
27,500
| – | – | 0.03% | 308 |
|
|
2013
Q3 | $1.08M | Sell |
27,500
-7,100
| -21% | -$264K | 0.03% | 320 |
|
|
2013
Q2 | $1.14M | Buy |
+34,600
| New | +$1.12M | 0.03% | 296 |
|
Other funds holding ACHC
Segall Bryant & Hamill's ACHC Position: Q3 2023 in Review
Segall Bryant & Hamill sold out of Acadia Healthcare (ACHC) in Q3 2023, closing a stake of 3,000 shares — an estimated $239K sold.
Segall Bryant & Hamill first reported a position in ACHC in Q2 2013 and held it in 33 quarters. The position peaked at $1.83M in Q2 2018. 293 funds tracked by Wall St. Rank hold ACHC as of Q3 2023.
- Segall Bryant & Hamill reported no remaining Acadia Healthcare position as of Q3 2023 after selling out during the quarter.
- Segall Bryant & Hamill sold 3,000 Acadia Healthcare shares in Q3 2023, an estimated $239K.
- Segall Bryant & Hamill first reported a position in Acadia Healthcare in Q2 2013 and held it in 33 quarters.
- Segall Bryant & Hamill's Acadia Healthcare position peaked at $1.83M in Q2 2018.
- 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2023.
Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.